BATS BZX Real-Time Price
As of 1:55pm ET
| +0.21 / +0.78%|
The 6 analysts offering 12-month price forecasts for Sagent Pharmaceuticals Inc have a median target of 31.50, with a high estimate of 38.00 and a low estimate of 27.00. The median estimate represents a +15.68% increase from the last price of 27.23.
The current consensus among 8 polled investment analysts is to Hold stock in Sagent Pharmaceuticals Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.